Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Boadie W. Dunlop

14 indexed publications match this author name.

ORCID: 0000-0002-4653-0483
OpenAlex: https://openalex.org/A5056637382

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 12 Treatment-Resistant Depression 9 Clinical Trial 9 Chronic Pain 6 Toxicity 6 Mechanism of Action 4 Randomized Controlled Trial 4 Safety 3 Adverse Events 2 Emotional Processing 2 Review Article 2 Anxiety 2

Journals

Journal of Affective Disorders 2 Neuroscience Applied 2 The Journal of Clinical Psychiatry 1 BMC Psychiatry 1 Psychotherapy 1 Med 1 JAMA 1 New England Journal of Medicine 1

Publication history

Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09 Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive DisorderThe Journal of Clinical Psychiatry · 2025-03-02 Prolonged adverse effects from repeated psilocybin use in an underground psychedelic therapy training program: a case reportBMC Psychiatry · 2025-02-27 Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges.Unknown journal · 2025-02-05 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy · 2025-01-12 The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17 Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinMed · 2024-02-13 Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30 Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02 Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31 Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language ProcessingPsyArXiv · 2022-09-29 The efficacy of COMP360 psilocybin therapy in treatment-resistant depression: exploratory results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31 The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trialNeuroscience Applied · 2021-12-31 Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.Unknown journal · 2021-12-31

Author directory